Cintas Corp. (CTAS) Tops Q3 EPS by 10c, Beats on Revenues
Get Alerts CTAS Hot Sheet
Price: $223.74 -0.46%
Revenue Growth %: +8.2%
Financial Fact:
Total revenue: 1.29B
Today's EPS Names:
FUSE, INM, TRI, More
Revenue Growth %: +8.2%
Financial Fact:
Total revenue: 1.29B
Today's EPS Names:
FUSE, INM, TRI, More
Join SI Premium – FREE
Note: EPS may not be comparable
Cintas Corp. (NASDAQ: CTAS) reported Q3 EPS of $1.37, $0.10 better than the analyst estimate of $1.27. Revenue for the quarter came in at $1.59 billion versus the consensus estimate of $1.57 billion.
For earnings history and earnings-related data on Cintas Corp. (CTAS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Ultragenyx Pharma (RARE) Misses Q3 EPS by 6c; Offers Guidance
- Tarsus Pharmaceuticals, Inc. (TARS) Misses Q3 EPS by 1293c
- Everus Construction Group, Inc. (ECG) Tops Q3 EPS by 101c ; Offers Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!





Tweet
Share